MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, KPTI made $35,066K in revenue. -$22,392K in net income. Net profit margin of -63.86%.

Income Overview

Revenue
$35,066K
Net Income
-$22,392K
Net Profit Margin
-63.86%
EPS
-$1.24
Unit: Thousand (K) dollars
Revenue Breakdown
    • Gross product revenue
    • Provisions for product revenue
    • License And Other

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue from contract with customer, license and other revenue
35,066 34,079 44,044 37,929
Cost of sales
1,345 1,484 2,113 1,051
Research and development
33,797 27,667 30,544 32,788
Selling, general and administrative
26,684 22,772 26,607 28,477
Total operating expenses
61,826 51,923 59,264 62,316
Loss from operations
-26,760 -17,844 -15,220 -24,387
Interest income
511 607 553 613
Interest expense
12,553 12,619 11,008 11,228
(loss) gain on extinguishment of debt
--62,365 0 0
Other income, net
16,411 -10,044 -7,418 -2,210
Total other income, net
4,369 -84,421 -17,873 -12,825
Loss before income taxes
-22,391 -102,265 -33,093 -37,212
Income tax provision
1 -67 34 40
Net loss
-22,392 -102,198 -33,127 -37,252
Basic EPS
-1.02 -5,683.666 -3.82 -4.32
Diluted EPS
-1.24 -5,683.666 -3.82 -4.32
Basic Average Shares
22,014 17,981 8,669 8,620
Diluted Average Shares
24,715 17,981 8,669 8,620
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$22,392K (4.56%↑ Y/Y)Other income, net$16,411K (-17.22%↓ Y/Y)Gross product revenue$37,307K Interest income$511K (-48.90%↓ Y/Y)Loss before incometaxes-$22,391K (4.42%↑ Y/Y)Income tax provision$1K (-97.22%↓ Y/Y)Total other income,net$4,369K (-55.55%↓ Y/Y)Product$29,163K (38.52%↑ Y/Y)License And Other$5,903K (-34.13%↓ Y/Y)Interest expense$12,553K (14.18%↑ Y/Y)Provisions for productrevenue$8,144K Loss from operations-$26,760K (19.53%↑ Y/Y)Revenue from contractwith customer,...$35,066K (16.83%↑ Y/Y)Total operatingexpenses$61,826K (-2.28%↓ Y/Y)Research and development$33,797K (-2.37%↓ Y/Y)Selling, general andadministrative$26,684K (-2.44%↓ Y/Y)Cost of sales$1,345K (3.38%↑ Y/Y)

Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Inc. (KPTI)